Juno Therapeutics Stock Return On Asset
Juno Therapeutics fundamentals help investors to digest information that contributes to Juno Therapeutics' financial success or failures. It also enables traders to predict the movement of Juno Stock. The fundamental analysis module provides a way to measure Juno Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Juno Therapeutics stock.
Juno |
Juno Therapeutics Company Return On Asset Analysis
Juno Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Juno Therapeutics Return On Asset | -0.17 |
Most of Juno Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Juno Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Juno Therapeutics has a Return On Asset of -0.1707. This is 98.05% lower than that of the sector and 99.28% lower than that of the Return On Asset industry. The return on asset for all United States stocks is 21.93% higher than that of the company.
Juno Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Juno Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Juno Therapeutics could also be used in its relative valuation, which is a method of valuing Juno Therapeutics by comparing valuation metrics of similar companies.Juno Therapeutics is currently under evaluation in return on asset category among related companies.
Juno Fundamentals
| Return On Equity | -0.21 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (342.91) % | |||
| Current Valuation | 8.92 B | |||
| Shares Outstanding | 116.11 M | |||
| Shares Owned By Insiders | 13.58 % | |||
| Shares Owned By Institutions | 80.59 % | |||
| Number Of Shares Shorted | 8.19 M | |||
| Price To Earning | (15.21) X | |||
| Price To Book | 8.60 X | |||
| Price To Sales | 94.75 X | |||
| Revenue | 106.56 M | |||
| Gross Profit | 111.87 M | |||
| EBITDA | (350.85 M) | |||
| Net Income | (353.85 M) | |||
| Cash And Equivalents | 927.53 M | |||
| Cash Per Share | 8.18 X | |||
| Total Debt | 10.01 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 4.77 X | |||
| Book Value Per Share | 14.11 X | |||
| Cash Flow From Operations | (201.61 M) | |||
| Short Ratio | 3.36 X | |||
| Earnings Per Share | (3.39) X | |||
| Number Of Employees | 589 | |||
| Beta | 3.25 | |||
| Market Capitalization | 10.1 B | |||
| Total Asset | 1.45 B | |||
| Retained Earnings | (726.68 M) | |||
| Working Capital | 832.11 M | |||
| Current Asset | 951.84 M | |||
| Current Liabilities | 119.73 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Juno Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Juno Therapeutics' short interest history, or implied volatility extrapolated from Juno Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Juno Stock
If you are still planning to invest in Juno Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Juno Therapeutics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |